Scholarlink

Purpose <p>To assess whether preoperative non-contrast CT-derived adiposity quantity and attenuation are independently associated with recurrence-free survival (RFS) after surgery for localized clear cell renal cell carcinoma (ccRCC).</p> Methods <p>We performed a single-center retrospective cohort study of adults with pathologically confirmed ccRCC who underwent upfront partial or radical nephrectomy and had preoperative non-contrast abdominal CT within 30&#xa0;days. A single mid-L3 axial slice was segmented for subcutaneous (SAT) and visceral adipose tissue (VAT) using predefined thresholds (SAT−190 to −30 HU; VAT−150 to−50 HU). Adiposity indices were normalized by height squared (SATI, VATI), and mean SAT/VAT attenuation (HU) was recorded. RFS was defined as time from surgery to first documented local/regional recurrence or distant metastasis. Multi-variable Cox models were adjusted for age, sex, chronic disease history, tumor diameter, surgery type, and WHO/ISUP grade; continuous predictors were standardized (per 1-SD). Incremental prognostic performance beyond the clinicopathologic base model was assessed using Harrell’s C-index.</p> Results <p>Among 598 patients, 151 (25.3%) developed recurrence/metastasis. Higher SATI and VATI were associated with longer RFS in separate adjusted models (per 1-SD: SATI HR 0.55, 95% CI 0.44–0.68; VATI HR 0.63, 0.53–0.76). Higher (less negative) attenuation was associated with shorter RFS in separate adjusted models (SAT HU HR 1.29, 1.12–1.48; VAT HU HR 1.40, 1.21–1.60). In joint models, the SATI association remained robust, whereas VATI and VAT attenuation were attenuated. The apparent C-index of the clinicopathologic base model improved from 0.667 to 0.707 after adding SATI and to 0.713 after adding SATI + VATI.</p> Conclusion <p>Routine preoperative non-contrast CT measures of adiposity quantity, and to a lesser extent attenuation, provide prognostic information for postoperative RFS in localized ccRCC. In this localized surgery-treated cohort, SATI was the most stable independent marker and modestly improved discrimination beyond clinicopathologic factors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Preoperative non-contrast CT-derived adiposity quantity and attenuation predict recurrence-free survival after nephrectomy for localized clear cell renal cell carcinoma

  • 期刊论文

  • 发表日期：

    2026年4月14日

查看全文
  • Zhongwei Ma,
  • Le Kang,
  • Yanghuang Zheng,
  • Meiwei Gong,
  • Xiaoshan Li,
  • Junhai Ma,
  • Panfeng Shang

摘要

Purpose

To assess whether preoperative non-contrast CT-derived adiposity quantity and attenuation are independently associated with recurrence-free survival (RFS) after surgery for localized clear cell renal cell carcinoma (ccRCC).

Methods

We performed a single-center retrospective cohort study of adults with pathologically confirmed ccRCC who underwent upfront partial or radical nephrectomy and had preoperative non-contrast abdominal CT within 30 days. A single mid-L3 axial slice was segmented for subcutaneous (SAT) and visceral adipose tissue (VAT) using predefined thresholds (SAT−190 to −30 HU; VAT−150 to−50 HU). Adiposity indices were normalized by height squared (SATI, VATI), and mean SAT/VAT attenuation (HU) was recorded. RFS was defined as time from surgery to first documented local/regional recurrence or distant metastasis. Multi-variable Cox models were adjusted for age, sex, chronic disease history, tumor diameter, surgery type, and WHO/ISUP grade; continuous predictors were standardized (per 1-SD). Incremental prognostic performance beyond the clinicopathologic base model was assessed using Harrell’s C-index.

Results

Among 598 patients, 151 (25.3%) developed recurrence/metastasis. Higher SATI and VATI were associated with longer RFS in separate adjusted models (per 1-SD: SATI HR 0.55, 95% CI 0.44–0.68; VATI HR 0.63, 0.53–0.76). Higher (less negative) attenuation was associated with shorter RFS in separate adjusted models (SAT HU HR 1.29, 1.12–1.48; VAT HU HR 1.40, 1.21–1.60). In joint models, the SATI association remained robust, whereas VATI and VAT attenuation were attenuated. The apparent C-index of the clinicopathologic base model improved from 0.667 to 0.707 after adding SATI and to 0.713 after adding SATI + VATI.

Conclusion

Routine preoperative non-contrast CT measures of adiposity quantity, and to a lesser extent attenuation, provide prognostic information for postoperative RFS in localized ccRCC. In this localized surgery-treated cohort, SATI was the most stable independent marker and modestly improved discrimination beyond clinicopathologic factors.